# Bell Pharmaceuticals, Inc - Inspection Records

Source: https://www.keypedia.com/companies/bell-pharmaceuticals-inc/bb92f552-7a5a-4a84-b282-4310321b816b

> Inspection records and compliance data for Bell Pharmaceuticals, Inc in Belle Plaine, Minnesota. Access full analysis and detailed observations.

---

## Details

- Name: Bell Pharmaceuticals, Inc
- FEI Number: 2123499
- City: Belle Plaine
- State: Minnesota
- Country Name: United States
- Address Line 1: 200 W Beaver St
- Zip Code: 56011

## Related Documents

- [483 - Bell Pharmaceuticals, Inc - 2025-06-18](https://www.keypedia.com/records/483/bell-pharmaceuticals-inc/ca17d9b1-2899-494f-aa5c-fc1b265b1f79) — source: FDA, date: June 18, 2025
- [FDA Inspection 1271571 - Bell Pharmaceuticals, Inc - 2025-06-18](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/1926ee2f-7dde-4b69-842d-0d7262eb1ed9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 18, 2025
- [EIR - Bell Pharmaceuticals, Inc - 2018-04-06](https://www.keypedia.com/records/eir/bell-pharmaceuticals-inc/f911fc8d-6534-44e6-a73b-eb9a70e498fe) — source: FDA, date: April 6, 2018
- [FDA Inspection 1047160 - Bell Pharmaceuticals, Inc - 2018-04-06](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/007d8ca2-c29a-4864-9c30-60730e44ee8f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 6, 2018
- [FDA Inspection 955992 - Bell Pharmaceuticals, Inc - 2015-11-20](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/4e2cc4c3-9240-4f27-8237-477595714bf1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2015
- [FDA Inspection 826998 - Bell Pharmaceuticals, Inc - 2013-04-05](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/9d791269-7da1-43fc-8b4d-f6c365418ff2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2013
- [FDA Inspection 697960 - Bell Pharmaceuticals, Inc - 2010-11-12](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/11a7ca0d-1523-4833-96e9-dee74e01ae6e) — classification: No Action Indicated (NAI), source: FDA, date: November 12, 2010
- [FDA Inspection 582576 - Bell Pharmaceuticals, Inc - 2009-05-15](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/e4f54e43-ffc6-4440-a948-f6ddf11751ae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 15, 2009

## Related Companies

- [G S Cosmeceutical USA Inc](https://www.keypedia.com/companies/g-s-cosmeceutical-usa-inc/02e5e566-9934-4417-9659-f041ee537843)
- [Spectrum Pharmaceuticals, Inc.](https://www.keypedia.com/companies/spectrum-pharmaceuticals-inc/d2be8240-3764-497f-8d0d-fbedb45f3053)
- [Pharbil Waltrop Gmbh](https://www.keypedia.com/companies/pharbil-waltrop-gmbh/f3455dea-04cf-4c53-ab8b-3fcddc45fb4c)
- [Buckeye International Inc](https://www.keypedia.com/companies/buckeye-international-inc/01799cae-da24-4d86-9a28-d25a72c9bc8b)
- [Columbia Cosmetics Manufacturing, Inc.](https://www.keypedia.com/companies/columbia-cosmetics-manufacturing-inc/c6e32c25-080a-4901-8391-8716d6517687)
- [Medline Industries, Inc.](https://www.keypedia.com/companies/medline-industries-inc/ab99df74-d4aa-44f4-aed8-fcb2d3e45280)
- [Arzol Chemical Company](https://www.keypedia.com/companies/arzol-chemical-company/08a68b2c-a246-449c-adcd-290d48a7ece4)
- [Marksans Pharma Limited](https://www.keypedia.com/companies/marksans-pharma-limited/0855d225-2181-468a-a51c-c479608c1c92)
- [McKenna Labs Inc](https://www.keypedia.com/companies/mckenna-labs-inc/a0956f9d-e7ea-4bf6-ac78-77140586f684)
- [Ajanta Pharma Ltd.](https://www.keypedia.com/companies/ajanta-pharma-ltd/040efb87-46b2-4747-b87d-c1d87daad1e7)

## Related Officers

- [Investigator](https://www.keypedia.com/people/andrew-j-idzior/5b639c02-d062-4a5a-aa4a-8362ddfba2b6)
- [Consumer Safety Officer](https://www.keypedia.com/people/brandy-n-lepage/41e679e3-cc2a-4361-bf89-26acbd7deaf8)